CLINICAL_TRIALS
ClinicalTrials.gov record update
Phase II Clinical and Pharmacokinetic Trial of PM00104 (Zalypsis®) in Patients With Advanced and/or Metastatic Endometrial or Cervical Cancer Previously Treated With One Line of Systemic Chemotherapy
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT00900562
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-28T10:38:26.218378+00:00
- Published At
- 2021-10-28T00:00:00+00:00
- Record Updated At
- 2021-10-28
- Results Posted At
- 2021-10-28
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Uterine Cervical Cancer", "Endometrial Cancer"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2021-10-28"- protocolSection.identificationModule.nctId
"NCT00900562"- protocolSection.identificationModule.officialTitle
"Phase II Clinical and Pharmacokinetic Trial of PM00104 (Zalypsis\u00ae) in Patients With Advanced and/or Metastatic Endometrial or Cervical Cancer Previously Treated With One Line of Systemic Chemotherapy"- protocolSection.statusModule.overallStatus
"TERMINATED"- protocolSection.designModule.phases
["PHASE2"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
"2021-10-28"
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.